54 -2 (30/2) — Sadikova D.I., Sahatalieva R.R., — FEATURES OF LEUKOPLAKIA OF THE BLADDER

FEATURES OF LEUKOPLAKIA OF THE BLADDER

Sadikova D.I. -Andijan State Medical Institute, 110000 Uzbekistan, Andijan Navoii avenyu 126.

Sahatalieva R.R. -Andijan State Medical Institute, 110000 Uzbekistan, Andijan Navoii avenyu 126.

Xamraev O.A. -Andijan State Medical Institute, 110000 Uzbekistan, Andijan Navoii avenyu 126.

Minavarova G., -Andijan State Medical Institute, 110000 Uzbekistan, Andijan Navoii avenyu 126.

Abdulazizov S.A. -Andijan State Medical Institute, 110000 Uzbekistan, Andijan Navoii avenyu 126.

Boboev R.A. -Andijan State Medical Institute, 110000 Uzbekistan, Andijan Navoii avenyu 126.

Khojiboev M.A. -Andijan State Medical Institute, 110000 Uzbekistan, Andijan Navoii avenyu 126.

Hojamberdiev U.E. -Andijan State Medical Institute, 110000 Uzbekistan, Andijan Navoii avenyu 126.

Resume,

45 patient women with leukoplakia of the bladder were examined. A direct correlation was established between the complaints of patients and the stage of leukoplakia of the mucous membrane of the bladder depending on the stage of development of the disease, the severity of pain and dysuric phenomena increase and reach their maximum in the third stage of the disease.

Keywords: leukoplakia, bladder, pain, mucous membrane, dysuria.

First page

215

Last page

218

For citation: Sadikova D.I., Sahatalieva R.R., Xamraev O.A., Minavarova G., Abdulazizov S.A., Boboev R.A., Khojiboev M.A., Hojamberdiev U.E., Features of leukoplakia of the bladder//New Day in Medicine 2(30)2020 215-218 https://cutt.ly/0cWqk1N

List of References

  1. Alekseeva V.E. Combined laser treatment of lower urinary tract diseases in women // Kremlin Medicine, Clinical Bulletin. 2015; 5: 14-15.
  2. Andreeva Yu.Yu. Intestinal metaplasia of the epithelium of the mucous membrane of the bladder / Pathology archive. 2012; 6: 56-57.
  3. Babicheva I.A. Pathogenetic approaches to surgical treatment of cervical leukoplakia // Obstetrics and gynecology. -2018; 2: 33-38.
  4. Balan V.E. Modern approaches to the management and treatment of women with urinary disorders // Obstetrics and gynecology. – 2006; 5: 65-67.
  5. Bocharova O.A. The role of adhesive disorders in the pathogenesis of leukoplakia and the possibility of their correction by an immunomodulator // Immunology. – 2014; 25(1): 36-43.
  6. Danilov V.V. Diagnostic and therapeutic aspects of urination disorders in women // Medical journal. 2016; 2: 20-25.
  7. Derevyanko I.I. Complicated urinary tract infections // Consilium Medicum. – 2017; 5(7): 376-380.
  8. Klimenko I.A. Candidomycotic cystitis and leukoplakia of the bladder // Urology and Nephrology. -2017; 3: 71-73.
  9. Klimenko I.A. Cytological examination in the diagnosis and follow­up of patients with precancerous diseases of the bladder // Laboratory work. 2013; 9: 544-547.
  10. Klimenko I.A. Clinical and morphological features of leukoplakia of the bladder / Oncology. 2016; 12(6): 76-81.
  11. Levin E.I. Cystitis in women: diagnosis and treatment. -M., 2009; 21-25.
  12. Lopatkin N.A. Uncomplicated and complicated urinary tract infections. The princi ples of antibiotic therapy // Russian Medical Journal. 2017; 5(24): 1579-1592.
  13. Laurent O.B. Features of the diagnosis and treatment of chronic cystitis in women // Obstetrics and gynecology. -2000; 3: 40-43.
  14. Getrova L.V. Mucosal androgen receptors in the oral mucosa in patients with leukoplakia // Bulletin of Dermatology and Venereology. 2018; 3: 4-5.
  15. Prilepskaya V.N. Diseases of the cervix, vagina and vulva: clinics. Lectures / – M.: Medpress-inform, 2013; 29-33.
  16. Romanenko A.M. Leukoplakia of the bladder // Archive of pathology. 2015; 1: 39-42.
  17. Shabad A.L. Clinical and biochemical features of leukoplakia of the bladder // Questions of Oncology. 2013; 2: 61-64.
  18. Hooton T. Recurrent urinary tract infection in women // International journal of antimicrobial agents. 2018; 17(4): 259­268.
  19. Morgan R. Vesical leukoplakia // Br J. Urology. 2010; 52: 96-100.
  20. Raz R. Hormone replacement therapy or prophylaxis in posfrnenopausal women with recurrent urinary tract infection / / Journal of Infectious Disseases. -2017; 183(1): 74-76.

file

download